Donepezil Ameliorates Pulmonary Arterial Hypertension by Inhibiting M2-Macrophage Activation
Background: The beneficial effects of parasympathetic stimulation in pulmonary arterial hypertension (PAH) have been reported. However, the specific mechanism has not been completely clarified. Donepezil, an oral cholinesterase inhibitor, enhances parasympathetic activity by inhibiting acetylcholine...
Main Authors: | Haihua Qiu, Yibo Zhang, Zhongyu Li, Ping Jiang, Shuhong Guo, Yi He, Yuan Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.639541/full |
Similar Items
-
Fasudil Dichloroacetate Alleviates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension by Ameliorating Dysfunction of Pulmonary Arterial Smooth Muscle Cells
by: Liu P, et al.
Published: (2021-04-01) -
Conditioned medium from M2b macrophages modulates the proliferation, migration, and apoptosis of pulmonary artery smooth muscle cells by deregulating the PI3K/Akt/FoxO3a pathway
by: Suiqing Huang, et al.
Published: (2020-05-01) -
Echinacoside prevents hypoxic pulmonary hypertension by regulating the pulmonary artery function
by: Xiangyun Gai, et al.
Published: (2020-12-01) -
Preventive treatment with ginsenoside Rb1 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats and involves store-operated calcium entry inhibition
by: Rui-Xing Wang, et al.
Published: (2020-01-01) -
Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
by: Yi Tong, et al.
Published: (2018-09-01)